(Q46313097)

English

A clinical trial evaluating the 24-hour effects of bisoprolol/hydrochlorothiazide 5 mg/6.25 mg combination in patients with mild to moderate hypertension

scientific article

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

21 December 2017

http://europepmc.org/abstract/MED/8222387

A clinical trial evaluating the 24-hour effects of bisoprolol/hydrochlorothiazide 5 mg/6.25 mg combination in patients with mild to moderate hypertension (English)

1 reference

Europe PubMed Central

21 December 2017

http://europepmc.org/abstract/MED/8222387

1 reference

based on heuristic

inferred from title

author name string

Lewin AJ

1

1 reference

Europe PubMed Central

21 December 2017

http://europepmc.org/abstract/MED/8222387

Lueg MC

2

1 reference

Europe PubMed Central

21 December 2017

http://europepmc.org/abstract/MED/8222387

Targum S

3

1 reference

Europe PubMed Central

21 December 2017

http://europepmc.org/abstract/MED/8222387

Cardenas P

4

1 reference

Europe PubMed Central

21 December 2017

http://europepmc.org/abstract/MED/8222387

publication date

1 October 1993

1 reference

Europe PubMed Central

21 December 2017

http://europepmc.org/abstract/MED/8222387

Clinical Cardiology

1 reference

Europe PubMed Central

21 December 2017

http://europepmc.org/abstract/MED/8222387

16

1 reference

Europe PubMed Central

21 December 2017

http://europepmc.org/abstract/MED/8222387

10

1 reference

Europe PubMed Central

21 December 2017

http://europepmc.org/abstract/MED/8222387

732-736

1 reference

Europe PubMed Central

21 December 2017

http://europepmc.org/abstract/MED/8222387

Placebo does not lower ambulatory blood pressure

1 reference

https://api.crossref.org/works/10.1002%2FCLC.4960161009

21 January 2018

Pharmacological Basis for Combination Therapy of Hypertension

1 reference

https://api.crossref.org/works/10.1002%2FCLC.4960161009

7 January 2021

based on heuristic

inferred from DOI database lookup

Combination therapy in hypertension

1 reference

https://api.crossref.org/works/10.1002%2FCLC.4960161009

7 January 2021

based on heuristic

inferred from DOI database lookup

Bisoprolol. A preliminary review of its pharmacodynamic and pharmacokinetic properties, and therapeutic efficacy in hypertension and angina pectoris

1 reference

https://api.crossref.org/works/10.1002%2FCLC.4960161009

7 January 2021

based on heuristic

inferred from DOI database lookup

Left ventricular hypertrophy in patients with hypertension: importance of blood pressure response to regularly recurring stress

1 reference

https://api.crossref.org/works/10.1002%2FCLC.4960161009

7 January 2021

based on heuristic

inferred from DOI database lookup

Validation of portable noninvasive blood pressure monitoring devices: comparisons with intra-arterial and sphygmomanometer measurements

1 reference

https://api.crossref.org/works/10.1002%2FCLC.4960161009

7 January 2021

based on heuristic

inferred from DOI database lookup

Ambulatory blood pressure monitoring in the evaluation of drug efficacy

1 reference

https://api.crossref.org/works/10.1002%2FCLC.4960161009

7 January 2021

based on heuristic

inferred from DOI database lookup

Usefulness of ambulatory monitoring of blood pressure in assessing antihypertensive therapy.

1 reference

https://api.crossref.org/works/10.1002%2FCLC.4960161009

7 January 2021

based on heuristic

inferred from DOI database lookup

Assessment of the daily blood pressure load as a determinant of cardiac function in patients with mild-to-moderate hypertension

1 reference

https://api.crossref.org/works/10.1002%2FCLC.4960161009

7 January 2021

based on heuristic

inferred from DOI database lookup

The circadian blood pressure pattern in ambulatory normal subjects

1 reference

https://api.crossref.org/works/10.1002%2FCLC.4960161009

7 January 2021

based on heuristic

inferred from DOI database lookup

The evolution of antihypertensive therapy: an overview of four decades of experience

1 reference

https://api.crossref.org/works/10.1002%2FCLC.4960161009

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.1002/CLC.4960161009

1 reference

Europe PubMed Central

21 December 2017

http://europepmc.org/abstract/MED/8222387

1 reference

Europe PubMed Central

21 December 2017

http://europepmc.org/abstract/MED/8222387

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q46313097&oldid=2104503138"